mRNA Therapeutics: Beyond Vaccines, Future Potential
Received Date: May 01, 2025 / Accepted Date: May 29, 2025 / Published Date: May 29, 2025
Abstract
mRNA therapeutics, driven by COVID-19 vaccine success, are rapidly transforming medicine beyond infectious diseases. This
versatile platform shows immense promise for cancer immunotherapy, genetic disorders, and cardiovascular conditions. Key advancements focus on optimizing mRNA delivery systems, stability, and translation efficiency, leveraging innovations like lipid
nanoparticles. While offering rapid adaptability and personalized treatment potential, challenges in manufacturing scalability, cold
chain logistics, and potential immunogenicity persist. Ongoing research is dedicated to refining mRNA design and delivery to overcome these hurdles, ultimately ensuring broader and more effective clinical applications across diverse human pathologies.
Keywords: mRNA therapeutics; mRNA vaccines; cancer immunotherapy; genetic disorders; cardiovascular diseases; drug delivery systems; lipid nanoparticles; CRISPR/Cas; precision medicine; vaccine development
Citation: Linford S (2025) mRNA Therapeutics: Beyond Vaccines, Future Potential. Arch Sci 09: 285. Doi: 10.4172/science.1000285
Copyright: © 2025 Sophia Linford This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 556
- [From(publication date): 0-0 - Apr 06, 2026]
- Breakdown by view type
- HTML page views: 422
- PDF downloads: 134
